New anesthesia drug may keep blood pressure more stable during robotic surgery

NCT ID NCT07251101

Not yet recruiting Knowledge-focused Sponsor: Ilsan Cha hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two anesthesia drugs—remimazolam and propofol—to see which one keeps blood pressure more stable during robot-assisted gynecologic surgery. 58 women under 65 will be randomly assigned to receive one of the drugs. The main goal is to measure blood pressure throughout the procedure. This is an early-stage trial that may help guide future anesthesia choices.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: remimazolam and propofol
What this could lead to: If remimazolam proves better at maintaining blood pressure, it could become a preferred anesthetic for robotic surgeries.
What could go wrong: This is a small, early-phase study (58 people) comparing two existing drugs, so results may not change practice. No major risks beyond standard anesthesia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANESTHESIA, INTRAVENOUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pneumoperitoneum

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANESTHESIA, INTRAVENOUS GYNECOLOGIC SURGERY HEMODYNAMIC STABILITY

Contacts and locations

Locations

CHA Ilsan Medical Center

Goyang-si, Gyeonggi-do, 10414, South Korea
CHA Ilsan Medical Center

Goyang-si, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.